Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8242746 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 6 Pages |
Abstract
Conclusions: The maximally tolerated/recommended phase II doses were capecitabine 600 mg/m2 twice daily, carboplatin AUC 1.5 weekly, and paclitaxel 45 mg/m2 weekly with RT to 50.4 Gy. In our small study, this regimen appears active but is accompanied by significant toxicities, primarily esophagitis.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Brian G. M.D., Chris R. M.D., Herbert I. M.D., Chris G. M.D., Michael A. M.D., Gerard C. M.D., Nishan H. M.D., Thomas A. M.D., David H. M.D., Wanda R.N., Daohai Ph.D., Johanna C. M.D.,